Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin. / Tsakiri, Anna; Tsiantoulas, Dimitris; Frederiksen, Jette; Svane, Inge Marie.

I: Experimental Neurology, Bind 221, Nr. 2, 01.02.2010, s. 320-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Tsakiri, A, Tsiantoulas, D, Frederiksen, J & Svane, IM 2010, 'Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin', Experimental Neurology, bind 221, nr. 2, s. 320-8. https://doi.org/10.1016/j.expneurol.2009.11.014

APA

Tsakiri, A., Tsiantoulas, D., Frederiksen, J., & Svane, I. M. (2010). Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin. Experimental Neurology, 221(2), 320-8. https://doi.org/10.1016/j.expneurol.2009.11.014

Vancouver

Tsakiri A, Tsiantoulas D, Frederiksen J, Svane IM. Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin. Experimental Neurology. 2010 feb. 1;221(2):320-8. https://doi.org/10.1016/j.expneurol.2009.11.014

Author

Tsakiri, Anna ; Tsiantoulas, Dimitris ; Frederiksen, Jette ; Svane, Inge Marie. / Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin. I: Experimental Neurology. 2010 ; Bind 221, Nr. 2. s. 320-8.

Bibtex

@article{1b619348f9e24c1794140fd1b391b08b,
title = "Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin",
abstract = "Multiple sclerosis (MS) is an autoimmune disease where myelin-reactive lymphocytes and their activation depend on interactions with antigen presenting cells (APCs). Dendritic cells (DC) are professional APCs dependent on maturation to attain full T-cell priming capacity. The immunomodulatory properties of simvastatin influence the function of both T cells and APCs and could thus be a potential therapy for MS. The phenotype of myeloid DC in untreated patients with monosymptomatic optic neuritis (ON) was determined by flow cytometry and the impact of simvastatin on the function of myeloid DC derived from peripheral blood mononuclear cells (PBMC) was analysed in vitro. DC from ON patients had more mature phenotype compared with healthy controls (HC). Particularly the fraction of DC expressing CD1a and CD80 was significantly higher in ON than in HC (P",
author = "Anna Tsakiri and Dimitris Tsiantoulas and Jette Frederiksen and Svane, {Inge Marie}",
note = "Copyright 2009 Elsevier Inc. All rights reserved.",
year = "2010",
month = feb,
day = "1",
doi = "http://dx.doi.org/10.1016/j.expneurol.2009.11.014",
language = "English",
volume = "221",
pages = "320--8",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press",
number = "2",

}

RIS

TY - JOUR

T1 - Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

AU - Tsakiri, Anna

AU - Tsiantoulas, Dimitris

AU - Frederiksen, Jette

AU - Svane, Inge Marie

N1 - Copyright 2009 Elsevier Inc. All rights reserved.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Multiple sclerosis (MS) is an autoimmune disease where myelin-reactive lymphocytes and their activation depend on interactions with antigen presenting cells (APCs). Dendritic cells (DC) are professional APCs dependent on maturation to attain full T-cell priming capacity. The immunomodulatory properties of simvastatin influence the function of both T cells and APCs and could thus be a potential therapy for MS. The phenotype of myeloid DC in untreated patients with monosymptomatic optic neuritis (ON) was determined by flow cytometry and the impact of simvastatin on the function of myeloid DC derived from peripheral blood mononuclear cells (PBMC) was analysed in vitro. DC from ON patients had more mature phenotype compared with healthy controls (HC). Particularly the fraction of DC expressing CD1a and CD80 was significantly higher in ON than in HC (P

AB - Multiple sclerosis (MS) is an autoimmune disease where myelin-reactive lymphocytes and their activation depend on interactions with antigen presenting cells (APCs). Dendritic cells (DC) are professional APCs dependent on maturation to attain full T-cell priming capacity. The immunomodulatory properties of simvastatin influence the function of both T cells and APCs and could thus be a potential therapy for MS. The phenotype of myeloid DC in untreated patients with monosymptomatic optic neuritis (ON) was determined by flow cytometry and the impact of simvastatin on the function of myeloid DC derived from peripheral blood mononuclear cells (PBMC) was analysed in vitro. DC from ON patients had more mature phenotype compared with healthy controls (HC). Particularly the fraction of DC expressing CD1a and CD80 was significantly higher in ON than in HC (P

U2 - http://dx.doi.org/10.1016/j.expneurol.2009.11.014

DO - http://dx.doi.org/10.1016/j.expneurol.2009.11.014

M3 - Journal article

VL - 221

SP - 320

EP - 328

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -

ID: 34073508